The PeopleCypher team consists of leading figures in genetics, oncology, and computer science. Each started this project to gauge the result of their work and to share their many years of experience and university know-how in scientific, clinical, and IT activities.

We are developing new technologies for early cancer detection using the power of next-generation sequencing. We developed a new method of DNA testing that can detect over 40 types of cancers with a low false-positive rate, through a single blood draw. Our method also bears in mind the security of data storage and individual privacy. Thanks to GeNIO we can suggest personalized therapies which, even if they fail to eliminate the tumor, can allow us to live with it, with a good quality of life and for a longer survival time.

PeopleCypher is a start-up company focused on the study and design of IT platforms for health and genetic data management based on blockchain technologies with the implementation of machine learning encoded systems.
Our registered office is in Cagliari (Italy) but our target market is worldwide.
We are a university spin-off and therefore we actively collaborate with Italian universities in order to achieve our goals.

PeopleCypher was born from the need to satisfy the growing health need. Our goal is to obtain personalized and accessible genetic information to make it usable and applicable within modern personalized medicine, thus refining the ability of doctors to use genomic approaches in patient care.” 

PeopleCypher is the solution that allows patients and doctors to act predictively and to develop effective and long-term therapies. During this process, considerable importance is given to the secure management of genetic data in an IT environment, thanks to the collaboration with some of the best cybersecurity experts in Europe.

Team

GeNIOExam

What We Do